icon-folder.gif   Conference Reports for NATAP  
  50th ICAAC
Boston, MA
September 12-15, 2010
Back grey_arrow_rt.gif
Switching from ABC/3TC + Efavirenz [EFV] to TDF/FTC/EFV [Atripla, ATR] Reduces Cholesterol in Hypercholesterolemic Subjects: 24-Week Final Results of a Randomised Study
  Reported by Jules Levin
ICAAC Sept 14 2010 Boston
G Moyle,1 C Orkin,2 M Fisher,3 J Dhar,4 J Anderson,5 J Ewan,6 H Wang7 and ROCKET I Study Group 1Chelsea and Westminster Hospital, London, UK; 2Barts and The London NHS Trust, London, UK; 3Brighton and Sussex University Hospitals, UK; 4Leicester Royal Infirmary, UK; 5Homerton University Hospital, London, UK; 6Gilead Sciences Ltd, Cambridge, UK; 7Gilead Sciences Inc, Foster City, US